The Essential Components of Your Drug’s Biomarker Strategy White Paper The Essential Components of Your Drug’s Biomarker Strategy CertaraJanuary 14, 2022
Moving Advanced Therapies to the Next Level – Tackling the Key Challenges When Transitioning from Nonclinical to Clinical Development White Paper Moving Advanced Therapies to the Next Level – Tackling the Key Challenges When Transitioning from Nonclinical to Clinical Development CertaraDecember 23, 2021
The Importance of Collecting Race/Ethnicity Information in Clinical Trials for Biologics – A Clinical Pharmacology Perspective White Paper The Importance of Collecting Race/Ethnicity Information in Clinical Trials for Biologics – A Clinical Pharmacology Perspective CertaraNovember 2, 2021
Using Real-world Evidence to Advance Market Access for New Therapeutics White Paper Using Real-world Evidence to Advance Market Access for New Therapeutics CertaraSeptember 29, 2021
FDA’s Digital Transformation Journey White Paper FDA’s Digital Transformation Journey CertaraAugust 19, 2021
Immunogenicity Prediction and Dose Optimization using Clinically-Validated In Silico Modeling & Simulation White Paper Immunogenicity Prediction and Dose Optimization using Clinically-Validated In Silico Modeling & Simulation CertaraAugust 19, 2021
Overcome Research Hurdles: Expert Guidance for Complex Generic Drug Development White Paper Overcome Research Hurdles: Expert Guidance for Complex Generic Drug Development Do expensive bioequivalence studies stall your generic drug approval? Learn how you can streamline complex…CertaraApril 15, 2021
Advancing Pediatric Drug Development Using Simcyp PBPK White Paper Advancing Pediatric Drug Development Using Simcyp PBPK CertaraMarch 4, 2021
Leveraging Biosimulation to Inform Optimal Use of COVID-19 Vaccines White Paper Leveraging Biosimulation to Inform Optimal Use of COVID-19 Vaccines CertaraFebruary 3, 2021
“Where do I start?”: Strategies for selecting the first dose for human clinical trials White Paper “Where do I start?”: Strategies for selecting the first dose for human clinical trials This guide to dose selection for first-in-human studies explains the conceptual framework, methods, and tools…CertaraDecember 22, 2020